FDA Adverse Event Injury Summary report: N

PROTEGE EVERFLEX SELF-EXPANDING STENT SYSTEM STANDARD

MDR report key: 7435712 · Received April 17, 2018

Report

Report Number
2183870-2018-00233
Event Type
Injury
Date Received
April 17, 2018
Date of Event
January 16, 2017
Report Date
April 17, 2018
Manufacturer
COVIDIEN
Product Code
FGE
PMA / PMN Number
K060057
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE/DATE OF BIRTH: MEAN AGE. SEX: MAJORITY GENDER. DATE OF EVENT: ESTIMATE BASED ON DATE OF PUBLICATION OF ARTICLE. LIVER TRANSPLANTATION 23 1133¿1142 2017 AASLD. DOI: 10.1002/LT.24737 RECEIVED OCTOBER 20, 2016; ACCEPTED (B)(6) 2017. SAFETY AND EFFICACY OF TRANSHEPATIC AND TRANSSPLENIC ACCESS FOR ENDOVASCULAR MANAGEMENT OF PORTAL VEIN COMPLICATIONS AFTER LIVER TRANSPLANTATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

EIGHTEEN (18) PATIENTS WITH WERE TREATED WITH PROTÉGÉ EVERFLEX, COOK SHEATH AND NON-MEDTRONIC DEVICES, 12 PATIENTS UNDERWENT STENT PLACEMENT IN THE MAIN PORTAL VEIN TO THE PROXIMAL RIGHT PORTAL VEIN ACROSS THE PORTAL VEIN ANATOMOTIC STENOSIS, THE PROXIMAL SUPERIOR MESENTERIC VEIN AND SPLENIC VEIN. IT WAS REPORTED ALL THE PATIENTS ENCOUNTERED FLANK PAIN TREATED WITH ANALGESICS. ONE (1) PATIENT SUFFERED RESTENOSIS WITH PARTIAL THROMBOSIS AT THE 3-MONTH FOLLOW-UP CT SCAN, THIS PATIENT WAS TREATED WITH BALLOON ANGIOPLASTY AND FURTHER STENTING. HOWEVER, MELENA RECURRED 6 MONTHS LATER CT AND DIRECT PORTAL VEIN VENOGRAPHY REVEALED EXTENSIVE IN-STENT THROMBOSIS. THROMBOLYSIS AND BALLOON ANGIOPLASTY WERE PERFORMED. FLOW WAS NOT RESTORED; THE PATIENT IS UNDERGOING CONSERVATIVE MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
278761 PROTEGE EVERFLEX SELF-EXPANDING STENT SYSTEM STANDARD CATHETER, BILIARY, DIAGNOSTIC FGE COVIDIEN

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention